The document discusses treatment options for locally advanced cervical cancer. It summarizes several meta-analyses and clinical trials that show concurrent chemoradiation (CCT-RT) is the standard of care, rather than neoadjuvant chemotherapy followed by surgery (NACT+Surgery). While some older trials showed a benefit of NACT+Surgery, most recent evidence suggests it does not provide benefits and adds unnecessary morbidity compared to CCT-RT. The takeaway message is that in clinical practice, only standard guidelines accepted by major organizations like NCCN and NCI should be followed, and experimental treatments belong only in clinical trials.